PTCT
PTC Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.71B
P/E Ratio
—
EPS
$-2.54
Beta
0.53
52W High
$87.50
52W Low
$43.17
50-Day MA
$68.99
200-Day MA
$68.12
Dividend Yield
—
Profit Margin
-22.60%
Forward P/E
50.51
PEG Ratio
0.81
About PTC Therapeutics Inc
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is headquartered in South Plainfield, New Jersey.
Fundamentals
| Revenue (TTM) | $827.11M |
| Gross Profit (TTM) | $306.42M |
| EBITDA | $-20.90M |
| Operating Margin | 16.50% |
| Return on Equity | -7740.00% |
| Return on Assets | -1.54% |
| Revenue/Share (TTM) | $10.26 |
| Book Value | $-2.52 |
| Price-to-Book | 1743.27 |
| Price-to-Sales (TTM) | 6.90 |
| EV/Revenue | 5.19 |
| EV/EBITDA | 6.88 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -76.80% |
| Shares Outstanding | $82.95M |
| Float | $73.16M |
| % Insiders | 7.38% |
| % Institutions | 117.89% |
Historical Volatility
HV 10-Day
32.09%
HV 20-Day
64.36%
HV 30-Day
55.64%
HV 60-Day
49.08%
HV Rank
81.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($90.93 target)
4
Strong Buy5
Buy5
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026